Truist Financial disclosed trading activity and issued price objective reports related to Edwards Lifesciences.

The entities involved

• Edwards Lifesciences →

  American medical technology company

  • Edwards Lifesciences develops products designed to treat advanced cardiovascular diseases.Fri 21:53
  • Edwards Lifesciences and LabCorp successfully adopted AI to drive revenue growth.Wed 17:53
• Truist Financial →

  American bank holding company, formerly known as BB&T Corporation

  • Corning saw rating changes and price target adjustments from Morgan Stanley and Truist Financial, alongside increased shareholding by the Czech National Bank.Sun 11:07
  • Retailers like Kroger and Walmart intensify competition in the grocery market, while Erste Group and Truist Financial report market movements.Sat 18:11
• SEC →

  Slovak company

  • CNBC reports on FED rate decisions and their impact on the Main Street economy and SEC yields.Sun 12:43
  • SEC filing reported institutional investment activity for the Global X Uranium ETF.Sun 10:57

Related events

• Truist Financial set a price objective on Trex Company, Inc. shares.Jun 26
• ConocoPhillips made required institutional filings with the SEC and reduced its price target on COP shares.Jul 25
• Truist Financial analysts dropped the target price for Deckers Outdoor on July 24, 2026.Jul 24
• Immunovant, Inc. disclosed a stock sale filing with the SEC, while Truist Financial boosted its target price for the company.Jul 10
• The SEC oversees financial filings and market activity.Jul 18